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Background: The mechanism for the development of thrombotic microangiopathy (TMA) during sepsis has only
been partially elucidated. TMA is recognized as a disease caused by various factors, and may be involved in the
emergence of organ damage in severe sepsis. Here we report a case of TMA that followed disseminated
intravascular coagulation (DIC) due to severe infection in a patient with a reduced ADAMTS-13 activity level.
Case presentation: An 86-year-old Japanese woman was admitted to our hospital because of low back pain and
fever. A careful evaluation led to a diagnosis of acute obstructive pyelonephritis due to a ureteral stone. Proteus
mirabilis was isolated from both blood and urine cultures. The patient developed systemic inflammatory response
syndrome and DIC, and was treated with antibiotics and daily continuous hemodiafiltration. Although infection and
the coagulation abnormalities due to DIC were successfully controlled, renal failure persisted and her consciousness
level deteriorated progressively in association with severe thrombocytopenia and microangiopathic hemolytic
anemia. We therefore suspected the presence of TMA and started plasma exchange, which resulted in an
impressive improvement in consciousness as well as the laboratory abnormalities. The ADAMTS-13 activity was 44%
and the patient tested negative for the ADAMTS-13 inhibitor prior to the initiation of plasma exchange. A renal biopsy
was performed to determine the etiology of acute renal injury, which revealed findings that were interpreted to
be compatible with the sequelae of TMA. The follow-up studies performed after the successful treatment of TMA
showed that her plasma ADAMTS-13 activity level remained persistently low. It is surmised that septic DIC
occurring in the presence of preexisting reduced ADAMTS-13 activity have led to the development of secondary
TMA in the present case.
Conclusion: The present case suggests that TMA can be superimposed on sepsis-induced DIC, and plasma
exchange is expected to be beneficial in such situations. Clinicians should consider the possibility of secondary
TMA that follows sepsis-induced DIC in certain indicative clinical settings.
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Severe infectious disease and systemic inflammatory
syndrome (SIRS) often cause disseminated intravascular
coagulation (DIC). Thrombotic microvascular occlusion
occurring during DIC is known to cause acute kidney
injury. Thrombotic thrombocytopenic purpura (TTP)
and hemolytic uremic syndrome (HUS) are also known
to cause thrombotic microvascular occlusion of various
organs including the kidney [1]. TTP and HUS are the
primary prototypes of a group of disorders characterized
by thrombocytopenia due to increased platelet aggrega-
tion and microangiopathic hemolytic anemia collect-
ively called thrombotic microangiopathy (TMA). DIC
and TMA are recognized as distinct disease states from
the viewpoint of the mechanism responsible for vascular
occlusion; DIC is characterized by activation of coagula-
tion pathways and excessive thrombin generation with
subsequent consumption and exhaustion of platelets
and coagulation factors. In contrast, platelet aggregation
resulting from endothelial damage plays an important
role in the pathogenesis of TMA (HUS/TTP); coagula-
tion tests such as prothrombin time, D-dimer and fi-
brinogen are generally normal in TMA [2]. Here, we
report a case of secondary TMA that followed DIC due
to severe infection resulting in acute kidney injury.
Plasma exchange was performed for the treatment of
TMA with favorable result in this patient.
Case presentation
The patient was an 86-year-old Japanese woman who had
been regularly visiting the Department of Neurology,
Shizuoka Red Cross Hospital, for the treatment of Parkinson
disease; the patient had a well-maintained activity of daily
living (ADL) score. A routine physical checkup was done
regularly and blood tests revealed no abnormal findings.
She was brought to the hospital because of low back pain
and fever, and was admitted in June 2010. On day 2 of
hospitalization, she began to have difficulty in moving.
The level of consciousness was E3V5M6 according to the
Glasgow coma scale, and she fell into shock state; her
blood pressure and pulse rate was 70/30 mmHg and
75/min, respectively, and temperature was 37.8°C; the res-
piration was distressed (24/min). Physical examination re-
vealed petechial hemorrhage on the soft and hard palates,
right cost-vertebral angle tenderness, and numerous ec-
chymoses and non-palpable petechiae of the legs. A plain
abdominal radiography revealed a calculus of the right
ureter.
The results of the laboratory studies on day 2 in the
hospital were as follows. Urinalysis showed proteinuria
and the urinary sediment contained 20–29 isomorphic
red blood cells per high-power field. The amount of pro-
teinuria could not be determined because the patient
rapidly became anuric in the hospital. Leukocytosis(10,900/μL), anemia (hemoglobin level of 10.6 g/dL),
and thrombocytopenia (4.5 × 104/μL) were present, and
immature granulocytes with cytoplasmic vacuolation
and Dohle bodies were identified in the peripheral blood.
Impaired coagulation was noted, including prolonged ac-
tivated partial thromboplastin time (APTT, 51 seconds)
and prothrombin time (PT, 18.8 seconds, 1.63 by INR),
as well as increased fibrin/fibrinogen degradation products
(FDP, 645 ug/mL), and plasminogen activator inhibitor 1
(PAI-1, 146.8 ng/mL). The D-dimer level, determined on
day 3, was 103.4 ug/mL. Inflammatory markers were
markedly elevated (CRP, 6.91 mg/dL; procalcitonin,
141.96 ng/mL). Indirect hyperbilirubinemia (1.3 mg/dL),
an increase in transaminases (AST, 407 IU/L; ALT,
101 IU/L) and an elevation in the serum lactate dehydro-
genase (LDH, 1160 IU/L) were also present. Laboratory
data associated with renal function showed elevations in
urea nitrogen (UN, 43.3 mg/dL) and serum creatinine
(2.09 mg/dL). The immunological profile showed normal
levels of immunoglobulin and complement, but positivity
for rheumatoid factor and antinuclear antibody (ANA; ×40)
was noted. Perinuclear ANCA, cytoplasmic ANCA, and
anti-glomerular basement membrane antibody all tested
negative. Computed tomography revealed right hydro-
nephrosis and hydroureter due to right ureteral stone.
Proteus mirabilis was isolated from both blood and
urine cultures.
After admission, renal failure developed rapidly, and
the level of her consciousness deteriorated. Intravenous
piperacillin/tazobactam (PIPC/TAZ) 6.75 gram per day
was started, and was subsequently switched to ampicil-
lin (AMPC, 4 g/day) and gentamycin (60 mg/day, i.e.,
1.7 mg/kg) based on the blood and urine culture results,
followed further later by ciprofloxacin (CPFX, 200 mg/day).
Anuria continued even despite the placement of DJ-
ureteral catheter for the right ureteral obstruction. The
laboratory profile on day 2 in the hospital fulfilled the
diagnostic criteria of DIC [3]. A marked elevation of serum
PAI-1 and a reduced protein C level were observed, indicat-
ing a secondary anti-fibrinolytic DIC state. Continuous
hemodiafiltration (CHDF) was performed to remove ex-
cessive cytokines in addition to the administration of
broad-spectrum antibiotics and a single infusion of anti-
thrombin III. In response to these therapies, severe in-
fection was successfully controlled, and DIC was well
managed, as evidenced by the normalization of APTT and
PT as well as the improved levels of FDP, fibrinogen and
PAI-1 (Table 1). Disturbed consciousness and renal failure,
however, persisted with sustained thrombocytopenia, high
LDH levels, anemia, and the appearance of schistocytes.
Since the patient’s infection and DIC had already been well
controlled, it was conjectured that the persistent abnormal-
ities (microangiopathic hemolytic anemia, thrombocytopenia
and clinical symptoms such as neurological disturbance
Table 1 Time courses of coagulation and inflammation profile associated with microangiopathic hemolytic parameters
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Platelet count (×104/μL) 23.0 4.5 2.2 2.3 2.4 1.0 3.2
LDH (mg/dL) 217 1160 2267 1836 1412 1482
Serum Cr (mg/dL) 0.51 2.09 3.35 3.82 4.07
APTT (seconds) 51 39 32 28
PT-INR 1.63 1.36 1.52 1.03 0.90 0.95
FDP (μg/mL) 645 259 60 30
D-dimer (μg/mL) 103.4
Fibrinogen (mg/dL) 206 425 537 526 566 588
Anti-thrombin III (%) 90 60 74 49 62
Protein-C (%) <1.0 23 <1.0 32
PAI-1 (ng/mL) 146.8 148.0 172.6 24.7 38.7
Procalcitonin (ng/mL) 141.9 195.1 125.6 94.9 33.6
CRP (mg/dL) 0.66 6.91 15.79 19.77 13.53 11.73
The coagulation profiles of APTT and PT were normalized on day 6 as a result of the treatment with antibiotics and continuous hemodiafiltration (CHDF).
Antithrombin III (1500 unit) was administered on day 3.
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started plasma exchange therapy on day 7, replacing the
CHDF treatment. After the commencement of plasma ex-
change, the level of her consciousness improved dramatic-
ally in association with several laboratory parameters
including the LDH level, the platelet count and the serum
haptoglobin level (Table 2). The ADAMTS-13 activities
measured by the well-established assay method [4] on
days 8 and 19 were 44% and 40.6% (normal, 70-120%) re-
spectively (Table 2); the ADAMTS-13 activity measured
after the improvement of all the TMA symptoms except
for renal injury was also subnormal (35.5% on day 86 and
33.0% on day 220, Table 2). It is to be noted that
ADAMTS-13 activity was never below 10% in our patient
even during the period of high disease activity, indicating
that this was not a case of typical primary TTP.
To determine the etiology of the renal disease which
was unresponsive to plasma exchange, renal biopsy was
performed on day 26. The specimen for light microscopy
contained 15 glomeruli; 7 exhibited global sclerosis, 2 se-
vere segmental sclerosis, and 2 exhibited only minor abnor-
malities. The remaining 4 glomeruli had dilated capillary
loops that were filled with red blood cells (Figure 1-A).
Aggregations of severe tubular necrosis were seen inTable 2 Time courses of the ADAMTS-13 activity and the micr
Day 8 Day 19 Day 25
Platelet count (×104/μL) 1.0 11.3 12.2
LDH (mg/dL) 1069 248 247
Schistocytes (%) 6.1 3.8
Haptoglobin (mg/dL) <10
ADAMTS-13 activity (%) 44 40.6
ADAMTS-13 inhibitor (−) (−)several foci (Figure 1-B). One of these glomeruli had an affer-
ent arteriole with occlusive intimal changes (Figure 1-C;
arrowhead) and what appeared to be a small intraluminal
thrombus (Figure 1-D; arrow). Arteriosclerotic fibrous
thickening of the intima was seen in the larger arteries.
Smaller interlobular arteries and arterioles, on the other
hand, showed occlusion or extensive narrowing of their
lumen which was interpreted to represent the sequel of
TMA (Figure 1-E). Fibrinoid necrosis of the vessel wall
was not observed. No obvious thrombi were observed in
the vascular lumina except for the above-mentioned mod-
est lesion in an afferent arteriole. Tubular atrophy and
interstitial fibrosis were seen in approximately 50% of the
cortical area. Immunofluorescence studies showed no im-
munoglobulin, complement or fibrinogen deposition in
the glomeruli or the blood vessels.
Although laboratory abnormalities related to second-
ary TMA improved dramatically with plasma exchange,
the clinical course indicated an irreversible course of the
patient’s renal failure. Hence, we discontinued plasma
exchange and started the patient on three-times-a-week
maintenance hemodialysis beginning on day 57. TMA
did not recur after the discontinuation of plasma ex-
change, although moderately decreased levels of plasmaoangiopathic hemolytic parameters
Day 31 Day 58 Day 86 Day 220
23.4 7.4 7.8 4.3





Figure 1 Histopathological findings of renal biopsy. (A) Light photomicrograph showing two glomeruli with widened capillary lumina
containing red blood cells (Hematoxylin and eosin stain; original magnification, ×200). (B) Severe tubular necrosis with a loss of cellular detail
(Hematoxylin and eosin stain; original magnification, ×400). (C, D) Serial sections of an afferent arteriole with obliterative intimal change (C;
arrowhead) and intraluminal thrombus formation (D; arrow) (Periodic acid silver methenamin stain; original magnification, ×400). (E) Smaller
interlobular arteries and arterioles showed occlusion or extensive narrowing of their lumen which was interpreted to represent the sequel of TMA
(D; Periodic acid-Schiff stain; original magnification, ×400).
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was transferred to another hospital for rehabilitation and
maintenance hemodialysis (Figure 2).
Discussion
The present case manifested with severe sepsis caused
by obstructive urinary tract infection (causative organism,
Proteus mirabilis), and the laboratory findings showed fea-
tures characteristic of DIC on day 2 of hospitalization.
Despite the normalization of the coagulation abnormal-
ities by the treatment for infection and DIC, the central
nervous system symptoms and renal injury did not im-
prove and the microangiopathic hemolytic anemia and
thrombocytopenia persisted. We thus adopted the plasmaexchange therapy based on the assumption that her clin-
ical symptoms reflected the features of secondary forms of
TMA rather than DIC at this point. The rapid deterior-
ation of consciousness that took place following admission
to the hospital and in the context of old age and severe
sepsis could well have been a form of nonspecific delirium.
However, the fact that the patient’s mental state improved
dramatically with plasma exchange therapy suggests that
the deterioration was part of the TMA syndrome. Conse-
quently, significant improvements in the central nervous
system symptoms and the laboratory findings were ob-
served, although the renal dysfunction persisted. A renal
biopsy performed on day 26 showed multilayering of the
small arteries and arterioles with occlusive thickening of
Figure 2 Clinical course of the patient. The clinical course indicated that the patient’s renal failure was irreversible, although laboratory
abnormalities related to TMA improved with plasma exchange. Thus, we discontinued plasma exchange and started the patient on three-times-a-week
maintenance hemodialysis beginning on day 57.
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not demonstrated, except for a minute lesion in one affer-
ent arteriole shown in Figure 1-D, these changes were
interpreted as being compatible with the sequelae of renal
TMA. The absence of obvious fresh thrombi could be due
to the point of time of the biopsy as well as the thera-
peutic effects. The presence of focal severe tubular necro-
sis was suggestive of cortical necrosis. Although cortical
necrosis often results from DIC, its presence in TMA has
also been well documented, especially in HUS [5]. Al-
though the different forms of TMA entities (primary vs.
secondary) and TMA vs. DIC are difficult to differentiate
histologically, the above renal biopsy findings interpreted
in the context of the clinical course suggested that renal
TMA superimposed on DIC led to the severe renal failure
in our patient. Thus, TMA that followed DIC resulting
from the severe infection was thought to contribute im-
portantly to the disease process in the present case.
Acquired TMAs (HUS/TTP) include idiopathic and
secondary cases. Secondary TMA may occur in a variety of
disorders including collagen disease (e.g., SLE, rheumatoidarthritis, and scleroderma), malignant hypertension, in-
fection caused by Shiga-like toxin-producing Escheri-
chia coli (STEC) or non-STEC. The disorder is also
caused by drugs such as cyclosporine A, mitomycin C,
cisplatin and transplantation [6]. The autoantibody to
ADAMTS-13, a specific cleavage enzyme of von Willeb-
rand factor (VWF), was found to be involved in the de-
velopment of TTP, and the congenital ADAMTS-13
deficiency due to gene mutations was reported [7]. Fur-
thermore, under low ADAMTS-13 activity, ultra-large
VWF (UL-VWF) multimers are increased because the
low level of ADAMTS-13 fails to cleave UL-VWF multi-
mers, resulting in excessive platelet aggregation and the
subsequent microvascular occlusion and organ dysfunc-
tion. In the present case, physical examination and la-
boratory findings clearly eliminated the diagnosis of
collagen vascular diseases or STEC infection. The possi-
bility of malignant hypertension was ruled out by the
pre- and post-hospitalization blood pressure records.
Alternatively, systemic inflammation has been shown
to be associated with ADAMTS-13 deficiency and a
Sakamaki et al. BMC Nephrology 2013, 14:260 Page 6 of 7
http://www.biomedcentral.com/1471-2369/14/260subsequent elevation in UL-VWF [8]. It is, thus, reasonably
inferred that the TMA in the present case is attributed to
severe infection.
It has frequently been reported that infectious diseases
cause TMA. Douglas et al. [9] showed that infection
other than STEC infection preceded TMA in 36 out of
65 cases. Coppo et al. [10] also reported the presence of
infectious diseases other than verotoxin-producing
Escherichia coli (VTEC) in 9 of 30 TMA cases. Further-
more, Booth et al. [11] reported that infectious disease
other than STEC infection was identified in 31 (7%) of
415 suspected TMA cases that were registered in the
Oklahoma TTP-HUS Registry treated with plasma ex-
change. The same authors analyzed 98 cases of TMA
with infection and reported that the causative organisms
included 41 species of bacteria, as well as various viruses
and fungi.
Of note, among the 31 cases with TMA in the Oklahoma
TTP-HUS Registry, 10 patients manifested abnormal co-
agulation profiles, although it remained uncertain whether
these were DIC cases incorrectly diagnosed as TMA or
the co-morbid state of DIC and TMA [11]. Wang et al.
[12] also reported two patients with severe infection who
most likely suffered from both DIC and TTP; both patients
presented with renal injury, purpura, thrombocytopenia,
and coagulation/fibrinolysis abnormalities characteristic of
DIC, as well as a markedly reduced ADAMTS-13 activity
level and positive ADAMTS-13 inhibitor. Ono et al. [13]
also reported decreased ADAMTS-13 activity levels in pa-
tients diagnosed as having sepsis-induced DIC with severe
renal injury, and these authors suggested that the de-
creased ADAMTS-13 level was attributable to the re-
duced hepatic production and enhanced degradation by
various proteases induced by DIC. In the present case, we
assume that the initial presenting clinical picture was that
of DIC, and TMA was superimposed somewhat later
in association with a moderate decrease (44%) in the
ADAMTS-13 activity.
Interestingly, the ADAMTS-13 activity level still
remained low (35.5%) at the time when the patient was
discharged from the hospital when her infection was
clinically in complete cure. Furthermore, TMA did not
recur when her ADAMTS-13 activity was 33.0% (day
220). These observations lead us to surmise that the
endothelial injury caused by severe sepsis superimposed
on preexisting subnormal levels of ADAMTS-13 activity
contributed to the development of TMA. Some clinical
and experimental reports lend support to such surmise;
although familial TTP often manifests during infancy,
about one-half of cases remains undiagnosed until mid-
childhood or later, with rare ADAMTS13-deficient indi-
viduals remaining free-of-disease throughout the third
decade of life [14]. In an animal study using ADAMTS-
13-deficient mice, Motto et al. [15] reported that TTPdid not develop under the naïve condition, but the injec-
tion of Shiga toxin actually induced a condition resem-
bling human TTP. These observations lend support to
the premise that the loss of ADAMTS-13 activity may
be necessary, but not sufficient for the induction of a
clinical episode of TTP.
It is widely accepted that plasma exchange is an effect-
ive modality of the treatment of congenital or idiopathic
form of TTP [1]. In the present case, plasma exchange
was started with an assumption that TMA was superim-
posed on DIC based on the observation that consciousness
disturbance and renal dysfunction as well as microangio-
pathic hemolytic anemia and thrombocytopenia persisted
after the successful correction of coagulation parameters by
the treatment of septic DIC. Following plasma exchange,
the patient’s consciousness improved remarkably in asso-
ciation with partial recovery of the hematological ab-
normalities. Of note, Nguyen et al. [16] also reported
beneficial effects of plasma exchange in sepsis associated
with a decrease in ADAMTS-13 activity. Our experience
suggests that TMA, which is effectively treatable with
plasma exchange, should be taken into consideration in
patients with septic DIC with a serious clinical course.
Conclusions
The present case manifested with clinical and patho-
logical features suggestive of TMA following recovery
from DIC due to severe sepsis. Although much remains
to be elucidated as regard to the mechanism for the de-
velopment of TMA, the decreased level of ADAMTS-13
would act in concert with other detrimental factors asso-
ciated with infection and DIC to induce TMA. To the
extent that plasma exchange is expected to provide
beneficial effects on TMA, this case should remind us of
the possibility of TMA that follows sepsis-induced DIC.
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